Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Bmy crawled time : 13:20 save search
Bristol Myers Squibb Enters Into $4 Billion Aggregate Accelerated Share Repurchase Agreements
Published: 2023-08-10 (Crawled : 13:20) - biospace.com/
MS | News 0 d | $92.09 1.58% 0.12% 2.9K
|
Finance
|
| O: -0.63%
H: 1.16%
C: -0.31%
BMY | $49.14 0.43% 0.2% 6.4M
|
Health Technology
|
| O: 0.78%
H: 1.41%
C: 0.33%
repurchase
Bristol Myers Squibb to Report Results for First Quarter 2023 on April 27, 2023
Published: 2023-03-09 (Crawled : 13:20) - biospace.com/
BMY | $49.14 0.43% 0.2% 6.4M
|
Health Technology
|
| O: 0.46%
H: 0.18%
C: -1.61%
report
Global Antiviral Therapies Market Anticipated to Gather $66,016.5 Million and Grow at 3.1% CAGR in the 2020-2027 Forecast Period [208-Pages] | Details by Research Dive
Published: 2023-01-27 (Crawled : 13:20) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 0
|
Health Technology
|
| O: 1.13%
H: 1.57%
C: 1.57%
JNJ | News | $149.12 0.82% 0.59% 440K
|
Health Technology
|
| O: -0.21%
H: 0.19%
C: -0.18%
GSK | News | $40.59 2.11% 0.1% 1.3K
|
Health Technology
|
| O: -0.03%
H: 0.3%
C: -0.08%
BMY | $49.14 0.43% 0.2% 6.4M
|
Health Technology
|
| O: 0.0%
H: 0.63%
C: -0.74%
ABBV | News | $167.89 0.89% 0.51% 3.6M
|
Health Technology
|
| O: -0.06%
H: 0.25%
C: -0.7%
research global antiviral market
Bristol Myers Squibb Announces TRANSCEND CLL 004 Trial of Breyanzi® (lisocabtagene maraleucel) Met Primary Endpoint of Complete Response Rate in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
Published: 2023-01-26 (Crawled : 13:20) - biospace.com/
BMY | $49.14 0.43% 0.2% 6.4M
|
Health Technology
|
| O: -0.08%
H: 0.12%
C: -0.16%
breyanzi leukemia trial response transcend
Mirati Therapeutics Announces Update for the Phase 3 SAPPHIRE Study
Published: 2022-12-02 (Crawled : 13:20) - prnewswire.com
BMY | $49.14 0.43% 0.2% 6.4M
|
Health Technology
|
| O: -0.63%
H: 0.98%
C: 0.95%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -1.42%
H: 7.07%
C: 6.71%
sapphire therapeutics update study
Antithrombin Market Size (2022-2030) Worth US$ 776.1 Million| Growth Plus Reports
Published: 2022-08-19 (Crawled : 13:20) - prnewswire.com
BMY | $49.14 0.43% 0.2% 6.4M
|
Health Technology
|
| O: 0.01%
H: 2.09%
C: 1.58%
plus growth market
Bristol Myers Squibb Completes Acquisition of Turning Point Therapeutics, Expanding Precision Oncology Portfolio
Published: 2022-08-17 (Crawled : 13:20) - biospace.com/
BMY | $49.14 0.43% 0.2% 6.4M
|
Health Technology
|
| O: -0.3%
H: 1.45%
C: 0.88%
acquisition
Frost & Sullivan Institute lauds Global Companies with Prestigious Enlightened Growth Leadership Awards
Published: 2022-08-04 (Crawled : 13:20) - prnewswire.com
ATGFF | $21.6023 -0.73% 0.95% 0
|
n/a
|
| O: -0.47%
H: 1.17%
C: 1.17%
CNXC | News P | $55.2 0.02% -0.11% 0
|
Information
|
| O: -0.26%
H: 0.77%
C: 0.06%
CRK | $9.73 2.21% 0.1% 1.5K
|
Energy Minerals
|
| O: -0.3%
H: 1.53%
C: -7.46%
CNC | $75.58 0.57% 1.22% 1.9M
|
Health Services
|
| O: 0.12%
H: 0.54%
C: 0.06%
BAM | $39.05 1.91% 0.0% 12
|
Finance
|
| O: 0.26%
H: 0.82%
C: 0.82%
BMY | $49.14 0.43% 0.2% 6.4M
|
Health Technology
|
| O: -0.27%
H: 0.22%
C: -0.92%
AVTR | $24.41 1.29% 3.89% 4.4M
|
Process Industries
|
| O: 0.17%
H: 0.17%
C: -0.59%
DXCM | $131.52 0.62% 0.6% 2.6K
|
Health Technology
|
| O: -0.17%
H: 0.6%
C: -0.78%
BLDR 4 | $178.21 0.67% 1.0% 1M
|
Producer Manufacturing
|
| O: -0.74%
H: 3.87%
C: 3.37%
AMZN S | $177.23 1.49% 2.0% 28M
|
Retail Trade
|
| O: 3.23%
H: 0.0%
C: 0.0%
ALGN | $300.82 0.62% 0.64% 330K
|
Health Technology
|
| O: 0.15%
H: 3.36%
C: 2.48%
AEIS F | $91.03 1.48% 1.49% 120K
|
Electronic Technology
|
| O: 2.29%
H: 3.16%
C: -0.94%
awards global companies growth
Purple Biotech Announces the Initiation of Phase 2 Study for CM24 in 2L PDAC PatientsDecision based on positive interim Phase 1b data in pancreatic ductal adenocarcinoma (PDAC)
Published: 2022-05-18 (Crawled : 13:20) - biospace.com/
BMY | $49.14 0.43% 0.2% 6.4M
|
Health Technology
|
| O: 1.57%
H: 0.0%
C: 0.0%
cm24 biotech purple positive pancreatic phase 2 phase 2b
Global Rheumatology Therapeutics Market Research Report to 2027 - Featuring AbbVie, Amgen and Beckman Coulter Among Others
Published: 2022-04-26 (Crawled : 13:20) - prnewswire.com
SNYNF | News | $92.7 -2.18% 77
|
Health Technology
|
| O: -1.81%
H: 0.0%
C: 0.0%
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
|
| O: 3.09%
H: 0.0%
C: -2.9%
UCBJY | $64.93 0.61% -4.38% 6.1K
|
Manufacturing
|
| O: -0.33%
H: 0.0%
C: -1.56%
TMO | News | $548.38 0.66% 0.86% 1.2M
|
Health Technology
|
| O: -1.19%
H: 0.0%
C: 0.0%
TAK | News | $13.36 0.91% 0.0% 1.5M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
PFE | News A | $26.26 1.0% 0.27% 110K
|
Health Technology
|
| O: 3.08%
H: 0.0%
C: 0.0%
JNJ | News | $149.12 0.82% 0.59% 440K
|
Health Technology
|
| O: 2.0%
H: 0.0%
C: 0.0%
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
|
| O: 0.34%
H: 1.41%
C: -1.17%
BMY | $49.14 0.43% 0.2% 6.4M
|
Health Technology
|
| O: -0.09%
H: 1.26%
C: -0.51%
VRTX | $399.92 1.43% 1.45% 1.1M
|
Health Technology
|
| O: -0.22%
H: 0.43%
C: -1.25%
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
RIGL | $1.13 4.63% 3.57% 3.3M
|
Health Technology
|
| O: -0.38%
H: 4.92%
C: -4.55%
REGN | News | $900.16 0.37% 0.32% 240K
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
GILD | $66.95 0.29% 0.28% 2.1K
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: -0.03%
H: 0.53%
C: -1.33%
research report therapeutics market
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
PEGY | $0.0458 -10.2% 28.77% 79M
|
Manufacturing
PALI | $4.93 4.67% 25.83% 2.1M
|
Manufacturing
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
CANG | $1.34 -4.29% 14.93% 120K
|
Technology Services
AZTR 4 | $0.195 13.85% 42K
|
n/a
TOVX | News | $0.411 -1.01% 12.9% 230K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.